nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP1A2—type 2 diabetes mellitus	0.134	0.602	CbGaD
Propafenone—Quinapril—Ramipril—type 2 diabetes mellitus	0.0965	0.512	CrCrCtD
Propafenone—Benazepril—Ramipril—type 2 diabetes mellitus	0.092	0.488	CrCrCtD
Propafenone—CYP3A4—type 2 diabetes mellitus	0.0888	0.398	CbGaD
Propafenone—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0244	0.0612	CbGbCtD
Propafenone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0196	0.0492	CbGbCtD
Propafenone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0157	0.0394	CbGbCtD
Propafenone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0149	0.0374	CbGbCtD
Propafenone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0142	0.0356	CbGbCtD
Propafenone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0137	0.0343	CbGbCtD
Propafenone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0133	0.0333	CbGbCtD
Propafenone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0131	0.0328	CbGbCtD
Propafenone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0126	0.0317	CbGbCtD
Propafenone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0125	0.0314	CbGbCtD
Propafenone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0116	0.0292	CbGbCtD
Propafenone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0103	0.0259	CbGbCtD
Propafenone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0101	0.0254	CbGbCtD
Propafenone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00988	0.0248	CbGbCtD
Propafenone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00988	0.0248	CbGbCtD
Propafenone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00959	0.0241	CbGbCtD
Propafenone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00912	0.0229	CbGbCtD
Propafenone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00904	0.0227	CbGbCtD
Propafenone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00892	0.0224	CbGbCtD
Propafenone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00881	0.0221	CbGbCtD
Propafenone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00834	0.0209	CbGbCtD
Propafenone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00806	0.0202	CbGbCtD
Propafenone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00797	0.02	CbGbCtD
Propafenone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00795	0.02	CbGbCtD
Propafenone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00754	0.0189	CbGbCtD
Propafenone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00749	0.0188	CbGbCtD
Propafenone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00727	0.0183	CbGbCtD
Propafenone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00718	0.018	CbGbCtD
Propafenone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00685	0.0172	CbGbCtD
Propafenone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00663	0.0167	CbGbCtD
Propafenone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00659	0.0166	CbGbCtD
Propafenone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00657	0.0165	CbGbCtD
Propafenone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00635	0.016	CbGbCtD
Propafenone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00575	0.0144	CbGbCtD
Propafenone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00513	0.0129	CbGbCtD
Propafenone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00506	0.0127	CbGbCtD
Propafenone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00491	0.0123	CbGbCtD
Propafenone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00463	0.0116	CbGbCtD
Propafenone—ABCB1—Losartan—type 2 diabetes mellitus	0.00449	0.0113	CbGbCtD
Propafenone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00435	0.0109	CbGbCtD
Propafenone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00417	0.0105	CbGbCtD
Propafenone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00417	0.0105	CbGbCtD
Propafenone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00395	0.00992	CbGbCtD
Propafenone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00294	0.00739	CbGbCtD
Propafenone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00269	0.00676	CbGbCtD
Propafenone—Mirabegron—ADRB3—type 2 diabetes mellitus	0.000393	0.106	CrCbGaD
Propafenone—Carvedilol—GJA1—type 2 diabetes mellitus	0.00035	0.094	CrCbGaD
Propafenone—Carvedilol—NPPB—type 2 diabetes mellitus	0.00035	0.094	CrCbGaD
Propafenone—Bopindolol—ADRB3—type 2 diabetes mellitus	0.00032	0.0861	CrCbGaD
Propafenone—Carvedilol—HIF1A—type 2 diabetes mellitus	0.000265	0.0713	CrCbGaD
Propafenone—Labetalol—ADRB3—type 2 diabetes mellitus	0.00023	0.0617	CrCbGaD
Propafenone—Carvedilol—ADRB3—type 2 diabetes mellitus	0.000158	0.0425	CrCbGaD
Propafenone—Benazepril—MTHFR—type 2 diabetes mellitus	0.000141	0.0379	CrCbGaD
Propafenone—Quinapril—ACE—type 2 diabetes mellitus	0.000132	0.0355	CrCbGaD
Propafenone—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000122	0.0328	CrCbGaD
Propafenone—Propranolol—ADRB3—type 2 diabetes mellitus	0.00012	0.0323	CrCbGaD
Propafenone—Benazepril—ACE—type 2 diabetes mellitus	0.000115	0.0309	CrCbGaD
Propafenone—Carvedilol—VEGFA—type 2 diabetes mellitus	0.000107	0.0287	CrCbGaD
Propafenone—Mirabegron—CYP3A4—type 2 diabetes mellitus	8.18e-05	0.022	CrCbGaD
Propafenone—Salmeterol—CYP3A4—type 2 diabetes mellitus	7.48e-05	0.0201	CrCbGaD
Propafenone—Carvedilol—ADRA2A—type 2 diabetes mellitus	7.15e-05	0.0192	CrCbGaD
Propafenone—Mirabegron—ALB—type 2 diabetes mellitus	7.14e-05	0.0192	CrCbGaD
Propafenone—Oxaprozin—PTGS2—type 2 diabetes mellitus	5.79e-05	0.0156	CrCbGaD
Propafenone—Salsalate—PTGS2—type 2 diabetes mellitus	5.79e-05	0.0156	CrCbGaD
Propafenone—Benzphetamine—ADRA2A—type 2 diabetes mellitus	5.77e-05	0.0155	CrCbGaD
Propafenone—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	5.52e-05	0.0148	CrCbGaD
Propafenone—Atomoxetine—HTR2C—type 2 diabetes mellitus	5.27e-05	0.0142	CrCbGaD
Propafenone—Carvedilol—CYP2E1—type 2 diabetes mellitus	5.22e-05	0.014	CrCbGaD
Propafenone—Carvedilol—CYP1A2—type 2 diabetes mellitus	4.97e-05	0.0134	CrCbGaD
Propafenone—Shock—Metformin—type 2 diabetes mellitus	4.53e-05	0.000326	CcSEcCtD
Propafenone—Insomnia—Orlistat—type 2 diabetes mellitus	4.52e-05	0.000326	CcSEcCtD
Propafenone—Malaise—Losartan—type 2 diabetes mellitus	4.52e-05	0.000326	CcSEcCtD
Propafenone—Anxiety—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000326	CcSEcCtD
Propafenone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.52e-05	0.000325	CcSEcCtD
Propafenone—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.52e-05	0.000325	CcSEcCtD
Propafenone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.51e-05	0.000325	CcSEcCtD
Propafenone—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.51e-05	0.000325	CcSEcCtD
Propafenone—Vertigo—Losartan—type 2 diabetes mellitus	4.5e-05	0.000324	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000324	CcSEcCtD
Propafenone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.5e-05	0.000324	CcSEcCtD
Propafenone—Somnolence—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000324	CcSEcCtD
Propafenone—Syncope—Losartan—type 2 diabetes mellitus	4.5e-05	0.000324	CcSEcCtD
Propafenone—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.49e-05	0.000323	CcSEcCtD
Propafenone—Leukopenia—Losartan—type 2 diabetes mellitus	4.49e-05	0.000323	CcSEcCtD
Propafenone—Discomfort—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000323	CcSEcCtD
Propafenone—Skin disorder—Metformin—type 2 diabetes mellitus	4.48e-05	0.000322	CcSEcCtD
Propafenone—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000321	CcSEcCtD
Propafenone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.45e-05	0.000321	CcSEcCtD
Propafenone—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000321	CcSEcCtD
Propafenone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000321	CcSEcCtD
Propafenone—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.44e-05	0.000319	CcSEcCtD
Propafenone—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000319	CcSEcCtD
Propafenone—Palpitations—Losartan—type 2 diabetes mellitus	4.43e-05	0.000319	CcSEcCtD
Propafenone—Nausea—Glimepiride—type 2 diabetes mellitus	4.42e-05	0.000318	CcSEcCtD
Propafenone—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000318	CcSEcCtD
Propafenone—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.41e-05	0.000317	CcSEcCtD
Propafenone—Nausea—Sitagliptin—type 2 diabetes mellitus	4.4e-05	0.000317	CcSEcCtD
Propafenone—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000317	CcSEcCtD
Propafenone—Asthenia—Glyburide—type 2 diabetes mellitus	4.4e-05	0.000317	CcSEcCtD
Propafenone—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000317	CcSEcCtD
Propafenone—Anorexia—Metformin—type 2 diabetes mellitus	4.39e-05	0.000316	CcSEcCtD
Propafenone—Cough—Losartan—type 2 diabetes mellitus	4.38e-05	0.000315	CcSEcCtD
Propafenone—Urticaria—Gliclazide—type 2 diabetes mellitus	4.37e-05	0.000315	CcSEcCtD
Propafenone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000315	CcSEcCtD
Propafenone—Alopecia—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000314	CcSEcCtD
Propafenone—Fatigue—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000314	CcSEcCtD
Propafenone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.35e-05	0.000314	CcSEcCtD
Propafenone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.35e-05	0.000314	CcSEcCtD
Propafenone—Oedema—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000313	CcSEcCtD
Propafenone—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000313	CcSEcCtD
Propafenone—Pruritus—Glyburide—type 2 diabetes mellitus	4.34e-05	0.000312	CcSEcCtD
Propafenone—Mental disorder—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000312	CcSEcCtD
Propafenone—Constipation—Valsartan—type 2 diabetes mellitus	4.33e-05	0.000312	CcSEcCtD
Propafenone—Infection—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000311	CcSEcCtD
Propafenone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000311	CcSEcCtD
Propafenone—Fatigue—Orlistat—type 2 diabetes mellitus	4.31e-05	0.00031	CcSEcCtD
Propafenone—Hypotension—Metformin—type 2 diabetes mellitus	4.31e-05	0.00031	CcSEcCtD
Propafenone—Erythema—Ramipril—type 2 diabetes mellitus	4.3e-05	0.00031	CcSEcCtD
Propafenone—Malnutrition—Ramipril—type 2 diabetes mellitus	4.3e-05	0.00031	CcSEcCtD
Propafenone—Shock—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000308	CcSEcCtD
Propafenone—Pain—Orlistat—type 2 diabetes mellitus	4.28e-05	0.000308	CcSEcCtD
Propafenone—Myalgia—Losartan—type 2 diabetes mellitus	4.27e-05	0.000307	CcSEcCtD
Propafenone—Chest pain—Losartan—type 2 diabetes mellitus	4.27e-05	0.000307	CcSEcCtD
Propafenone—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.27e-05	0.000307	CcSEcCtD
Propafenone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000307	CcSEcCtD
Propafenone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000307	CcSEcCtD
Propafenone—Anxiety—Losartan—type 2 diabetes mellitus	4.25e-05	0.000306	CcSEcCtD
Propafenone—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000306	CcSEcCtD
Propafenone—Rash—Bromocriptine—type 2 diabetes mellitus	4.23e-05	0.000305	CcSEcCtD
Propafenone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.23e-05	0.000304	CcSEcCtD
Propafenone—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000304	CcSEcCtD
Propafenone—Tension—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000304	CcSEcCtD
Propafenone—Discomfort—Losartan—type 2 diabetes mellitus	4.22e-05	0.000304	CcSEcCtD
Propafenone—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000303	CcSEcCtD
Propafenone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000303	CcSEcCtD
Propafenone—Headache—Bromocriptine—type 2 diabetes mellitus	4.2e-05	0.000303	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.2e-05	0.000302	CcSEcCtD
Propafenone—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.2e-05	0.000302	CcSEcCtD
Propafenone—Nervousness—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000301	CcSEcCtD
Propafenone—Dry mouth—Losartan—type 2 diabetes mellitus	4.17e-05	0.000301	CcSEcCtD
Propafenone—Anorexia—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.000298	CcSEcCtD
Propafenone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000298	CcSEcCtD
Propafenone—Paraesthesia—Metformin—type 2 diabetes mellitus	4.14e-05	0.000298	CcSEcCtD
Propafenone—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000298	CcSEcCtD
Propafenone—Confusional state—Losartan—type 2 diabetes mellitus	4.13e-05	0.000297	CcSEcCtD
Propafenone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.12e-05	0.000297	CcSEcCtD
Propafenone—Dyspnoea—Metformin—type 2 diabetes mellitus	4.11e-05	0.000296	CcSEcCtD
Propafenone—Somnolence—Metformin—type 2 diabetes mellitus	4.1e-05	0.000295	CcSEcCtD
Propafenone—Oedema—Losartan—type 2 diabetes mellitus	4.09e-05	0.000295	CcSEcCtD
Propafenone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.09e-05	0.000294	CcSEcCtD
Propafenone—Infection—Losartan—type 2 diabetes mellitus	4.07e-05	0.000293	CcSEcCtD
Propafenone—Hypotension—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000293	CcSEcCtD
Propafenone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000292	CcSEcCtD
Propafenone—Dyspepsia—Metformin—type 2 diabetes mellitus	4.06e-05	0.000292	CcSEcCtD
Propafenone—Tremor—Ramipril—type 2 diabetes mellitus	4.03e-05	0.00029	CcSEcCtD
Propafenone—Shock—Losartan—type 2 diabetes mellitus	4.03e-05	0.00029	CcSEcCtD
Propafenone—Urticaria—Valsartan—type 2 diabetes mellitus	4.02e-05	0.000289	CcSEcCtD
Propafenone—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.01e-05	0.000289	CcSEcCtD
Propafenone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.01e-05	0.000289	CcSEcCtD
Propafenone—Decreased appetite—Metformin—type 2 diabetes mellitus	4.01e-05	0.000288	CcSEcCtD
Propafenone—Abdominal pain—Valsartan—type 2 diabetes mellitus	4e-05	0.000288	CcSEcCtD
Propafenone—Tachycardia—Losartan—type 2 diabetes mellitus	3.99e-05	0.000288	CcSEcCtD
Propafenone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000287	CcSEcCtD
Propafenone—Nausea—Bromocriptine—type 2 diabetes mellitus	3.99e-05	0.000287	CcSEcCtD
Propafenone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.98e-05	0.000286	CcSEcCtD
Propafenone—Fatigue—Metformin—type 2 diabetes mellitus	3.97e-05	0.000286	CcSEcCtD
Propafenone—Urticaria—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000286	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000285	CcSEcCtD
Propafenone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.96e-05	0.000285	CcSEcCtD
Propafenone—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000285	CcSEcCtD
Propafenone—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000285	CcSEcCtD
Propafenone—Asthenia—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.000285	CcSEcCtD
Propafenone—Constipation—Metformin—type 2 diabetes mellitus	3.94e-05	0.000284	CcSEcCtD
Propafenone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000281	CcSEcCtD
Propafenone—Anorexia—Losartan—type 2 diabetes mellitus	3.9e-05	0.000281	CcSEcCtD
Propafenone—Vomiting—Glyburide—type 2 diabetes mellitus	3.9e-05	0.000281	CcSEcCtD
Propafenone—Pruritus—Gliclazide—type 2 diabetes mellitus	3.9e-05	0.000281	CcSEcCtD
Propafenone—Malaise—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000279	CcSEcCtD
Propafenone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.88e-05	0.000279	CcSEcCtD
Propafenone—Rash—Glyburide—type 2 diabetes mellitus	3.87e-05	0.000278	CcSEcCtD
Propafenone—Somnolence—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000278	CcSEcCtD
Propafenone—Dermatitis—Glyburide—type 2 diabetes mellitus	3.86e-05	0.000278	CcSEcCtD
Propafenone—Vertigo—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000278	CcSEcCtD
Propafenone—Syncope—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000278	CcSEcCtD
Propafenone—Leukopenia—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000277	CcSEcCtD
Propafenone—Headache—Glyburide—type 2 diabetes mellitus	3.84e-05	0.000277	CcSEcCtD
Propafenone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000276	CcSEcCtD
Propafenone—Hypotension—Losartan—type 2 diabetes mellitus	3.82e-05	0.000275	CcSEcCtD
Propafenone—Palpitations—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000274	CcSEcCtD
Propafenone—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.8e-05	0.000273	CcSEcCtD
Propafenone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000272	CcSEcCtD
Propafenone—Propranolol—CYP1A2—type 2 diabetes mellitus	3.78e-05	0.0102	CrCbGaD
Propafenone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000272	CcSEcCtD
Propafenone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.77e-05	0.000271	CcSEcCtD
Propafenone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.77e-05	0.000271	CcSEcCtD
Propafenone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.00027	CcSEcCtD
Propafenone—Cough—Ramipril—type 2 diabetes mellitus	3.75e-05	0.00027	CcSEcCtD
Propafenone—Fatigue—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.00027	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.73e-05	0.000268	CcSEcCtD
Propafenone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.73e-05	0.000268	CcSEcCtD
Propafenone—Convulsion—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000268	CcSEcCtD
Propafenone—Pain—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000268	CcSEcCtD
Propafenone—Constipation—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000268	CcSEcCtD
Propafenone—Insomnia—Losartan—type 2 diabetes mellitus	3.7e-05	0.000267	CcSEcCtD
Propafenone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000265	CcSEcCtD
Propafenone—Paraesthesia—Losartan—type 2 diabetes mellitus	3.67e-05	0.000265	CcSEcCtD
Propafenone—Urticaria—Metformin—type 2 diabetes mellitus	3.66e-05	0.000264	CcSEcCtD
Propafenone—Chest pain—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000264	CcSEcCtD
Propafenone—Myalgia—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000264	CcSEcCtD
Propafenone—Dyspnoea—Losartan—type 2 diabetes mellitus	3.65e-05	0.000263	CcSEcCtD
Propafenone—Anxiety—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000263	CcSEcCtD
Propafenone—Nausea—Glyburide—type 2 diabetes mellitus	3.64e-05	0.000262	CcSEcCtD
Propafenone—Abdominal pain—Metformin—type 2 diabetes mellitus	3.64e-05	0.000262	CcSEcCtD
Propafenone—Dizziness—Gliclazide—type 2 diabetes mellitus	3.64e-05	0.000262	CcSEcCtD
Propafenone—Somnolence—Losartan—type 2 diabetes mellitus	3.64e-05	0.000262	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000262	CcSEcCtD
Propafenone—Asthenia—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000261	CcSEcCtD
Propafenone—Discomfort—Ramipril—type 2 diabetes mellitus	3.62e-05	0.00026	CcSEcCtD
Propafenone—Dyspepsia—Losartan—type 2 diabetes mellitus	3.6e-05	0.000259	CcSEcCtD
Propafenone—Asthenia—Orlistat—type 2 diabetes mellitus	3.59e-05	0.000258	CcSEcCtD
Propafenone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.58e-05	0.000258	CcSEcCtD
Propafenone—Pruritus—Valsartan—type 2 diabetes mellitus	3.58e-05	0.000258	CcSEcCtD
Propafenone—Dry mouth—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000258	CcSEcCtD
Propafenone—Decreased appetite—Losartan—type 2 diabetes mellitus	3.56e-05	0.000256	CcSEcCtD
Propafenone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000256	CcSEcCtD
Propafenone—Confusional state—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000255	CcSEcCtD
Propafenone—Pruritus—Orlistat—type 2 diabetes mellitus	3.54e-05	0.000255	CcSEcCtD
Propafenone—Fatigue—Losartan—type 2 diabetes mellitus	3.53e-05	0.000254	CcSEcCtD
Propafenone—Oedema—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000253	CcSEcCtD
Propafenone—Vomiting—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000252	CcSEcCtD
Propafenone—Pain—Losartan—type 2 diabetes mellitus	3.5e-05	0.000252	CcSEcCtD
Propafenone—Constipation—Losartan—type 2 diabetes mellitus	3.5e-05	0.000252	CcSEcCtD
Propafenone—Rash—Gliclazide—type 2 diabetes mellitus	3.47e-05	0.00025	CcSEcCtD
Propafenone—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.47e-05	0.00025	CcSEcCtD
Propafenone—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.46e-05	0.000249	CcSEcCtD
Propafenone—Urticaria—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000249	CcSEcCtD
Propafenone—Shock—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000249	CcSEcCtD
Propafenone—Headache—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000248	CcSEcCtD
Propafenone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000248	CcSEcCtD
Propafenone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000248	CcSEcCtD
Propafenone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000248	CcSEcCtD
Propafenone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000247	CcSEcCtD
Propafenone—Tachycardia—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000247	CcSEcCtD
Propafenone—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.42e-05	0.000246	CcSEcCtD
Propafenone—Skin disorder—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000245	CcSEcCtD
Propafenone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000244	CcSEcCtD
Propafenone—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.37e-05	0.000243	CcSEcCtD
Propafenone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.35e-05	0.000241	CcSEcCtD
Propafenone—Dizziness—Valsartan—type 2 diabetes mellitus	3.35e-05	0.000241	CcSEcCtD
Propafenone—Anorexia—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000241	CcSEcCtD
Propafenone—Dizziness—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000238	CcSEcCtD
Propafenone—Asthenia—Metformin—type 2 diabetes mellitus	3.31e-05	0.000238	CcSEcCtD
Propafenone—Carvedilol—CYP3A4—type 2 diabetes mellitus	3.29e-05	0.00885	CrCbGaD
Propafenone—Hypotension—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000236	CcSEcCtD
Propafenone—Nausea—Gliclazide—type 2 diabetes mellitus	3.27e-05	0.000236	CcSEcCtD
Propafenone—Pruritus—Metformin—type 2 diabetes mellitus	3.26e-05	0.000235	CcSEcCtD
Propafenone—Urticaria—Losartan—type 2 diabetes mellitus	3.25e-05	0.000234	CcSEcCtD
Propafenone—Body temperature increased—Losartan—type 2 diabetes mellitus	3.23e-05	0.000233	CcSEcCtD
Propafenone—Abdominal pain—Losartan—type 2 diabetes mellitus	3.23e-05	0.000233	CcSEcCtD
Propafenone—Vomiting—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000232	CcSEcCtD
Propafenone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000231	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.2e-05	0.00023	CcSEcCtD
Propafenone—Rash—Valsartan—type 2 diabetes mellitus	3.19e-05	0.00023	CcSEcCtD
Propafenone—Dermatitis—Valsartan—type 2 diabetes mellitus	3.19e-05	0.00023	CcSEcCtD
Propafenone—Vomiting—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000229	CcSEcCtD
Propafenone—Insomnia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000229	CcSEcCtD
Propafenone—Headache—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000228	CcSEcCtD
Propafenone—Diarrhoea—Metformin—type 2 diabetes mellitus	3.15e-05	0.000227	CcSEcCtD
Propafenone—Rash—Orlistat—type 2 diabetes mellitus	3.15e-05	0.000227	CcSEcCtD
Propafenone—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000227	CcSEcCtD
Propafenone—Dermatitis—Orlistat—type 2 diabetes mellitus	3.15e-05	0.000227	CcSEcCtD
Propafenone—Headache—Orlistat—type 2 diabetes mellitus	3.13e-05	0.000226	CcSEcCtD
Propafenone—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000225	CcSEcCtD
Propafenone—Asthenia—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000225	CcSEcCtD
Propafenone—Somnolence—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000225	CcSEcCtD
Propafenone—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000222	CcSEcCtD
Propafenone—Pruritus—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000222	CcSEcCtD
Propafenone—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.05e-05	0.00022	CcSEcCtD
Propafenone—Dizziness—Metformin—type 2 diabetes mellitus	3.05e-05	0.000219	CcSEcCtD
Propafenone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000218	CcSEcCtD
Propafenone—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	3.03e-05	0.00814	CrCbGaD
Propafenone—Fatigue—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000218	CcSEcCtD
Propafenone—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.01e-05	0.000217	CcSEcCtD
Propafenone—Nausea—Valsartan—type 2 diabetes mellitus	3.01e-05	0.000216	CcSEcCtD
Propafenone—Constipation—Ramipril—type 2 diabetes mellitus	3e-05	0.000216	CcSEcCtD
Propafenone—Fentanyl—CYP3A4—type 2 diabetes mellitus	2.99e-05	0.00805	CrCbGaD
Propafenone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000214	CcSEcCtD
Propafenone—Nausea—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000214	CcSEcCtD
Propafenone—Asthenia—Losartan—type 2 diabetes mellitus	2.94e-05	0.000211	CcSEcCtD
Propafenone—Vomiting—Metformin—type 2 diabetes mellitus	2.93e-05	0.000211	CcSEcCtD
Propafenone—Rash—Metformin—type 2 diabetes mellitus	2.91e-05	0.000209	CcSEcCtD
Propafenone—Dermatitis—Metformin—type 2 diabetes mellitus	2.9e-05	0.000209	CcSEcCtD
Propafenone—Pruritus—Losartan—type 2 diabetes mellitus	2.9e-05	0.000208	CcSEcCtD
Propafenone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000208	CcSEcCtD
Propafenone—Headache—Metformin—type 2 diabetes mellitus	2.89e-05	0.000208	CcSEcCtD
Propafenone—Dizziness—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000207	CcSEcCtD
Propafenone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000207	CcSEcCtD
Propafenone—Diarrhoea—Losartan—type 2 diabetes mellitus	2.8e-05	0.000202	CcSEcCtD
Propafenone—Urticaria—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000201	CcSEcCtD
Propafenone—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.77e-05	0.0002	CcSEcCtD
Propafenone—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.77e-05	0.0002	CcSEcCtD
Propafenone—Vomiting—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000199	CcSEcCtD
Propafenone—Rash—Irbesartan—type 2 diabetes mellitus	2.74e-05	0.000197	CcSEcCtD
Propafenone—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.74e-05	0.000197	CcSEcCtD
Propafenone—Nausea—Metformin—type 2 diabetes mellitus	2.74e-05	0.000197	CcSEcCtD
Propafenone—Headache—Irbesartan—type 2 diabetes mellitus	2.72e-05	0.000196	CcSEcCtD
Propafenone—Dizziness—Losartan—type 2 diabetes mellitus	2.71e-05	0.000195	CcSEcCtD
Propafenone—Benzphetamine—CYP3A4—type 2 diabetes mellitus	2.65e-05	0.00714	CrCbGaD
Propafenone—Atomoxetine—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.00708	CrCbGaD
Propafenone—Vomiting—Losartan—type 2 diabetes mellitus	2.6e-05	0.000187	CcSEcCtD
Propafenone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000186	CcSEcCtD
Propafenone—Nausea—Irbesartan—type 2 diabetes mellitus	2.58e-05	0.000186	CcSEcCtD
Propafenone—Rash—Losartan—type 2 diabetes mellitus	2.58e-05	0.000186	CcSEcCtD
Propafenone—Dermatitis—Losartan—type 2 diabetes mellitus	2.58e-05	0.000186	CcSEcCtD
Propafenone—Headache—Losartan—type 2 diabetes mellitus	2.56e-05	0.000185	CcSEcCtD
Propafenone—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	2.54e-05	0.00682	CrCbGaD
Propafenone—Asthenia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000181	CcSEcCtD
Propafenone—Propranolol—CYP3A4—type 2 diabetes mellitus	2.5e-05	0.00673	CrCbGaD
Propafenone—Pruritus—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000179	CcSEcCtD
Propafenone—Nausea—Losartan—type 2 diabetes mellitus	2.43e-05	0.000175	CcSEcCtD
Propafenone—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000173	CcSEcCtD
Propafenone—Dizziness—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000167	CcSEcCtD
Propafenone—Vomiting—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000161	CcSEcCtD
Propafenone—Rash—Ramipril—type 2 diabetes mellitus	2.21e-05	0.000159	CcSEcCtD
Propafenone—Dermatitis—Ramipril—type 2 diabetes mellitus	2.21e-05	0.000159	CcSEcCtD
Propafenone—Headache—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000158	CcSEcCtD
Propafenone—Nausea—Ramipril—type 2 diabetes mellitus	2.08e-05	0.00015	CcSEcCtD
Propafenone—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.94e-06	8.23e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.91e-06	8.16e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.89e-06	8.12e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.88e-06	8.1e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.88e-06	8.1e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.88e-06	8.09e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.88e-06	8.09e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	8.07e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.86e-06	8.06e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.86e-06	8.06e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.84e-06	8.02e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.84e-06	8e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.83e-06	7.98e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.83e-06	7.98e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.8e-06	7.92e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.79e-06	7.91e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.79e-06	7.9e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.79e-06	7.9e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.77e-06	7.86e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.77e-06	7.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.77e-06	7.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.77e-06	7.85e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.76e-06	7.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.74e-06	7.81e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.73e-06	7.78e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.68e-06	7.67e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.67e-06	7.65e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.67e-06	7.65e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.66e-06	7.63e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.66e-06	7.63e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.66e-06	7.63e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.66e-06	7.63e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.66e-06	7.63e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.65e-06	7.61e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.63e-06	7.58e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.63e-06	7.57e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.63e-06	7.57e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.61e-06	7.54e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.61e-06	7.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.61e-06	7.52e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.61e-06	7.52e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.57e-06	7.46e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.57e-06	7.46e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.56e-06	7.43e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.52e-06	7.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.51e-06	7.32e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.49e-06	7.27e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.47e-06	7.23e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.46e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.46e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.46e-06	7.21e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.46e-06	7.21e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.43e-06	7.15e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.43e-06	7.15e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.39e-06	7.07e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.38e-06	7.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.38e-06	7.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.38e-06	7.04e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.37e-06	7.02e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	3.32e-06	6.92e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.32e-06	6.92e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.3e-06	6.89e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.29e-06	6.85e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.26e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.26e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.24e-06	6.76e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.23e-06	6.75e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.22e-06	6.72e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.22e-06	6.71e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.21e-06	6.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.2e-06	6.68e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.19e-06	6.66e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.16e-06	6.59e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.16e-06	6.59e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.15e-06	6.56e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.14e-06	6.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.11e-06	6.48e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.1e-06	6.47e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.09e-06	6.44e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.05e-06	6.37e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.05e-06	6.35e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.04e-06	6.35e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.01e-06	6.29e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.98e-06	6.22e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.98e-06	6.22e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.98e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.97e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.97e-06	6.19e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.96e-06	6.18e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.95e-06	6.16e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.95e-06	6.16e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.94e-06	6.13e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.93e-06	6.12e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.93e-06	6.11e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.93e-06	6.11e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.93e-06	6.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.92e-06	6.1e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.92e-06	6.09e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.91e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.9e-06	6.05e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.89e-06	6.02e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	6e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.84e-06	5.93e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.84e-06	5.92e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.83e-06	5.9e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.82e-06	5.88e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.82e-06	5.87e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	5.86e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.8e-06	5.85e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.78e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.77e-06	5.78e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-06	5.76e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.74e-06	5.71e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.74e-06	5.71e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.74e-06	5.71e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.73e-06	5.7e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.71e-06	5.66e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	5.63e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.69e-06	5.61e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.66e-06	5.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-06	5.52e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.63e-06	5.49e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.62e-06	5.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.61e-06	5.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.61e-06	5.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.61e-06	5.44e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	5.41e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.58e-06	5.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.56e-06	5.34e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.55e-06	5.33e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-06	5.31e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.54e-06	5.3e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.54e-06	5.29e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.52e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.51e-06	5.24e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.49e-06	5.2e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.48e-06	5.18e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.48e-06	5.17e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.47e-06	5.15e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.46e-06	5.14e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.45e-06	5.12e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-06	5.09e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	5.05e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.42e-06	5.05e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.41e-06	5.03e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.41e-06	5.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.41e-06	5.02e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-06	5e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-06	4.98e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.38e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.38e-06	4.95e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	4.94e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.36e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.36e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.34e-06	4.88e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.33e-06	4.87e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.32e-06	4.84e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.31e-06	4.81e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.3e-06	4.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.3e-06	4.79e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-06	4.76e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.27e-06	4.74e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.26e-06	4.72e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.26e-06	4.72e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.26e-06	4.71e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.26e-06	4.71e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.25e-06	4.7e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.25e-06	4.69e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-06	4.69e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.24e-06	4.68e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.23e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	4.52e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.16e-06	4.5e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.15e-06	4.49e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	4.38e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.09e-06	4.37e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.07e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.07e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.07e-06	4.32e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	4.3e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.03e-06	4.23e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	4.13e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.97e-06	4.1e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.96e-06	4.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.95e-06	4.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.95e-06	4.06e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.94e-06	4.05e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.94e-06	4.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	4.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.93e-06	4.02e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	4.02e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.92e-06	4.01e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.91e-06	3.99e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	3.97e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	3.96e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	3.94e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.88e-06	3.93e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.86e-06	3.87e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	3.77e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	3.77e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.81e-06	3.77e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	3.71e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.77e-06	3.7e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	3.68e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.74e-06	3.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.73e-06	3.61e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	3.55e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	3.55e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	3.52e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	3.52e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.68e-06	3.51e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	3.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.66e-06	3.47e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	3.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	3.43e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.6e-06	3.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.57e-06	3.27e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	3.25e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.54e-06	3.22e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.52e-06	3.16e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	3.15e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.49e-06	3.11e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.49e-06	3.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.47e-06	3.07e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.45e-06	3.02e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	3.01e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	3.01e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.34e-06	2.79e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	2.75e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	2.7e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.27e-06	2.65e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	2.43e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	2.32e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	2.32e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-06	2.12e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	9.54e-07	1.99e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.31e-07	1.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.83e-07	1.63e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.76e-07	1.62e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.63e-07	1.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.12e-07	1.07e-05	CbGpPWpGaD
